Skip to content

Journal Highlights: Guidelines for the practical stability studies of anticancer drugs

The Editor’s choice in the most recent edition of the EJHP is a report of a European consensus conference on guidelines for the practical stability studies of anticancer drugs.

The conference was held in France in May 2010, under the auspices of the French Society of Oncology Pharmacy (SFPO), to propose adapted rules on stability of anticancer drugs in practical situations and guidelines for performing corresponding stability studies.

The conference looked at such issues as acceptance limits of degradation for individual drugs and the use of validated stability indicating methods. The conference also focused on the need to perform more studies on the stability of biotherapies, including a minimum of three complementary separating methods and careful evaluation of submicronic aggregates.

Report of conference here
 

×

Deadline extended to July 15th

Problems caused by shortages are serious, threaten patient care and require urgent action.

Help us provide an overview of the scale of the problem, as well as insights into the impact on overall patient care.

Our aim is to investigate the causes of medicine and medical device shortages in the hospital setting,  while also gathering effective solutions and best practices implemented at local, regional, and national levels.

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.